This website uses cookies to enhance the user experience.
N

NORIMUN AS914 136 830

Research
Limited company
c/o Felleskjøpet Agri SA Skansen, v/Hallgeir Olsen Nedre Ila 20 7018 TRONDHEIM, Norge

NORIMUN AS

Closed at January 8th, 2025

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

Chairman of the board
Operation time
11 years
- Oct 1, 2014 to Jan 8, 2025
Type
Limited company
VAT registered
No
Number of employees
0

Ownership

Number of shares and share classes
1,244,253
1 share class
Total number of shareholders
3
companies
Belongs to group of

Financials

Total operating income 2023
1,062,170
NOK
Annual total result 2023
-1,202,962
NOK
Total equity 2023
1,057,952
NOK
Last update: Dec 31, 2024

Management

Board

NameRoleShares
Chairman
11.91 %
indirectly
Board Member-
Board Member
11.91 %
indirectly
Board Member
2.98 %
indirectly
Board Member
5.96 %
indirectly
Board Member-

Others

NameRoleShares
E
ERNST & YOUNG AS
Auditor-
F
FOLLO REGNSKAP SA
Accountant-

Top 10 individual shareholders

NameRoleShares
Board Member
11.91 %
indirectly
Chairman
11.91 %
indirectly
Board Member
5.96 %
indirectly
Board Member
2.98 %
indirectly
-
2.98 %
indirectly
Last update: Oct 13, 2023

Ownership

Company shareholders

NameShare classNumber of sharesShare
Ordinary shares
799,552
64.26 %
N
NOVELFISH AS
Ordinary shares
296,468
23.83 %
O
OREO AS
Ordinary shares
148,233
11.91 %
Last update: May 24, 2024

Group structure

  • Total operating income 2023: NOK 15,073,436,000
    Operating profit 2023: NOK 185,528,000
    Employees: 2595

Financials

in NOK

Summary

Year202320222021
Total operating income
1,062,170
227,000
316,832
Annual Total Result
-1,202,962
-8,306,009
-4,231,880
Total assets
1,407,249
5,262,141
12,537,279
Total liabilities
349,297
3,001,227
13,200,516
Total equity
1,057,952
2,260,914
-663,237

P&L

Year202320222021
Total operating income
1,062,170
227,000
316,832
Total operating costs
2,190,886
8,485,936
2,099,188
Operating result
-1,128,716
-8,258,936
-1,782,356
Financial income/costs
-74,246
-47,073
-2,449,525
Profit before tax
-1,202,962
-8,306,009
-4,231,880
Total tax & extraordinary income/cost
0
0
0
Annual Total Result
-1,202,962
-8,306,009
-4,231,880

Balance overview

Year202320222021
Total fixed assets
52,441
513,649
6,869,362
Total current assets
1,354,808
4,748,492
5,667,917
Total assets
1,407,249
5,262,141
12,537,279
Short term debt
349,297
3,001,227
1,200,516
Long term debt
0
0
12,000,000
Total liabilities
349,297
3,001,227
13,200,516
Contributed capital
1,244,253
15,121,456
3,769,334
Retained earnings
-186,301
-12,860,542
-4,432,571
Total equity
1,057,952
2,260,914
-663,237
Total equity and liabilities
1,407,249
5,262,141
12,537,279

Classification

Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology